All News

Ken Tarkoff, formerly at RelayHealth, is joining Syapse as its new CEO.

Too much screen time is also blamed for rising rates of childhood obesity and diabetes. NIH Director Francis Collins said social media is a "chicken or the egg" issue, because it's unclear if social media causes isolation or reflects it.

The proposed payment models could fill a void for gastroenterologists, a key field for Medicare given the high number of enrollees treated for colorectal cancer.

A concerning new study has found a significant gap in survival for cystic fibrosis patients in the United States and Canada. The 10-year advantage observed in Canadian patients could partially be explained by disparities in the countries’ healthcare systems, the researchers suggested.

For the first time, the rate of drug price increases has surpassed the increase of the cost of hospitalizations, which is an important turning point, said Charles J. Fazio, MD, medical director of HealthPartners, Inc, during a panel discussion at America’s Health Insurance Plans’ National Health Policy Conference.

Groups say the approach of the Republicans' plan moves away from prevention, which had been a chief aim of the Affordable Care Act. A large cut to the CDC would leave the future of the Diabetes Prevention Program unclear.

Researchers from the Mayo Clinic and Arizona State University’s Biodesign Institute have collaborated to identify biological markers in the blood of patients with Crohn’s disease, spurring optimism that a simple blood test could be developed to accurately diagnose the disease.

New research published in Nature Medicine has identified a broader population of individuals with breast cancer who can have therapeutic sensitivity to PARP inhibitors.

Verma is best-known as the designer of Indiana's Medicaid expansion program, which features a lockout provision for those who fail to pay premiums.

The FDA has approved Novartis’ ribociclib (Kisqali) for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.

Up to 24 million people would lose health coverage under the American Health Care Act, the Republican plan to replace the Affordable Care Act (ACA), according to a report released today by the Congressional Budget Office (CBO). That would include up to 14 million in the first year alone, or two-thirds of the 21 million who have gained coverage under the ACA.

The technology outlined in the study not only offers superior glucose control, but it also is being developed in forms that its creators say will be functional and discreet.

A new study, published in the Journal of the National Cancer Institute, has confirmed that mammographic density change following estrogen and progestin treatment increases the risk of breast cancer.

Low-value care and its detrimental effects have become a hot topic among medical professionals in recent years, but a new study suggests that many patients many not be aware of why the concept matters or what the term even means.

A recent study in Health Affairs assessed cost and utilization outcomes for 3 innovative care models for Medicare beneficiaries with cancer: oncology medical homes, patient navigator programs, and palliative care initiatives.

On May 4-5, 2017, The American Journal of Managed Care's ACO & Emerging Healthcare Delivery Coalition will head back to Scottsdale, Arizona, to bring together stakeholders from across the industry.

As health reform discussions progress, influential stakeholders have urged policy makers to consider increasing the flexibility of health savings account—eligible high-deductible health plans.

Patients with chronic obstructive pulmonary disease have a higher risk of falls, which a new study suggests could be explained by their altered walking patterns compared with healthy controls.

President Donald Trump is expected to name Scott Gottlieb, MD, a resident scholar with the American Enterprise Institute, to lead the FDA, according to reports. Gottlieb would replace Robert Califf, MD, who only took over the position February 2016 and stepped down less than a year later in January 2017.

With costs of care being more closely scrutinized, there has been a proliferation of value frameworks to help guide decision making for treatments. In a blog post for Health Affairs, Robert W. Dubois, MD, PhD, and Kimberly Westrich, MA, both of the National Pharmaceutical Council, provide possible considerations for advancing the field of value frameworks.

Advocates note that the cuts would put the nation's health system in reverse, away from stopping health problems before they get out of hand.

The selective BCR-ABL1 kinase inhibitor imatinib mesylate (Gleevec) has been found to be safe and effective following almost 11 years of follow-up in patients with chronic myeloid leukemia.

Several key clinical trials will be presented at the upcoming meeting in Washington, DC.

When people with diabetes experience symptoms of depression and/or anxiety, their risk of mortality increases-particularly for men with only depressive symptoms.

This week, the top managed care news included a bill from House Republicans to repeal and replace the Affordable Care Act, a new program at Walgreens to train pharmacists on an advanced cancer-care curriculum, and findings that health coaching helps the neediest patients most.

A study evaluating patients diagnosed with thyroid cancer who refused a clinical intervention for fear of being overdiagnosed has reported that the individuals feel isolated and anxious.